This past week I was in our corporate offices and one of our District Managers came up to me and said he had developed type 1 diabetes. Although he is 42 years old, his physician had told him that his pancreas had quit working. His first indication was a loss of about 45 pounds over a 4 month period. He had started on an SGLT-2i and thought the weight loss was a result of that medication.
Now that he was on both long acting and mealtime insulin he did not understand why he should stay on the SGLT-2i. I shared my reasons and pointed him to an article that one of our interns had completed.
In this month’s SGLT-2i special edition we have that article for you, along with some other valuable items to review.